S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

OTCMKTS:CPPSF - Cassiopea Stock Price, Forecast & News

$37.25
0.00 (0.00 %)
(As of 11/7/2019)
Add
Today's Range
$37.25
Now: $37.25
$37.25
50-Day Range
$37.25
MA: $38.34
$39.00
52-Week Range
$38.95
Now: $37.25
$40.49
Volume253 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts. The company was formerly known as Cosmo Dermatos S.r.l. Cassiopea S.p.A. was founded in 2013 and is based in Lainate, Italy.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:CPPSF
CUSIPN/A
CIKN/A
Phone39 02 86 89 11 24

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees12
Next Earnings DateN/A
OptionableNot Optionable

Receive CPPSF News and Ratings via Email

Sign-up to receive the latest news and ratings for CPPSF and its competitors with MarketBeat's FREE daily newsletter.


Cassiopea (OTCMKTS:CPPSF) Frequently Asked Questions

What is Cassiopea's stock symbol?

Cassiopea trades on the OTCMKTS under the ticker symbol "CPPSF."

What is the consensus analysts' recommendation for Cassiopea?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cassiopea in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cassiopea.

Has Cassiopea been receiving favorable news coverage?

News coverage about CPPSF stock has trended extremely negative this week, InfoTrie reports. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Cassiopea earned a news sentiment score of -4.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the company's share price in the near term. View News Stories for Cassiopea.

Who are Cassiopea's key executives?

Cassiopea's management team includes the folowing people:
  • Ms. Diana Harbort, CEO & Exec. Director (Age 53)
  • Dr. Hans Christoph Tanner, CFO & Head of Investor Relations (Age 68)
  • Mr. Marco Pasero, Chief Operating Officer (Age 53)
  • Dr. Luigi Moro, Chief Scientific Officer (Age 68)
  • Mr. Alessandro Mazzetti, Chief Medical Officer (Age 67)

How do I buy shares of Cassiopea?

Shares of CPPSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cassiopea's stock price today?

One share of CPPSF stock can currently be purchased for approximately $37.25.

What is Cassiopea's official website?

The official website for Cassiopea is http://www.cassiopea.com/.

How can I contact Cassiopea?

The company can be reached via phone at 39 02 86 89 11 24.


MarketBeat Community Rating for Cassiopea (OTCMKTS CPPSF)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about Cassiopea and other stocks. Vote "Outperform" if you believe CPPSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPPSF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel